Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection

A. Chamberland, M. Sylla, M. R. Boulassel, J. G. Baril, P. Côté, R. Thomas, B. Trottier, D. Rouleau, J. P. Routy, C. Tremblay

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The rapid evolution of HIV-1 is a major obstacle to viral eradication. Early antiretroviral therapy (ART) during primary HIV-1 infection could limit viral diversity. Eighteen patients recently infected with HIV-1 were selected. Nine initiated ART soon after enrolment and nine remained untreated. Replication-competent (RC) viruses were quanstified at baseline and after one year of follow-up. Viral diversity in the C2V5 envelope region was evaluated from plasma, peripheral blood mononuclear cells (PBMCs), and cell culture at both time points. The amount of RC virus in the treated group declined (median -5.42 infectious units per million [IUPM]) while it remained stable or increased in the untreated group (median +0.87 IUPM). At one year post infection, we observed a significant increase in diversity for the C2V5 (+0.150%) region, specifically in the hypervariable loops V4 (+0.73%) and V5 (+0.77%), in the untreated group. More importantly, viral diversity did not significantly increase in treated individuals during the first year post infection. Genetic diversity during primary infection remains low through the first year of infection. Early treatment could contribute to a decrease in RC viruses from PBMCs and to limitation of viral diversification in the viral reservoir. These findings may have relevance for the rational design of specific immunotherapeutic strategies.

Original languageEnglish
Pages (from-to)146-150
Number of pages5
JournalInternational Journal of STD and AIDS
Volume22
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Molecular Evolution
HIV-1
Virus Replication
Infection
Blood Cells
Therapeutics
Secondary Prevention
HIV Infections
Cell Culture Techniques

Keywords

  • Acute infection
  • Primary HIV-1
  • Sequence diversity
  • Treatment

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection. / Chamberland, A.; Sylla, M.; Boulassel, M. R.; Baril, J. G.; Côté, P.; Thomas, R.; Trottier, B.; Rouleau, D.; Routy, J. P.; Tremblay, C.

In: International Journal of STD and AIDS, Vol. 22, No. 3, 03.2011, p. 146-150.

Research output: Contribution to journalArticle

Chamberland, A, Sylla, M, Boulassel, MR, Baril, JG, Côté, P, Thomas, R, Trottier, B, Rouleau, D, Routy, JP & Tremblay, C 2011, 'Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection', International Journal of STD and AIDS, vol. 22, no. 3, pp. 146-150. https://doi.org/10.1258/ijsa.2010.010292
Chamberland, A. ; Sylla, M. ; Boulassel, M. R. ; Baril, J. G. ; Côté, P. ; Thomas, R. ; Trottier, B. ; Rouleau, D. ; Routy, J. P. ; Tremblay, C. / Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection. In: International Journal of STD and AIDS. 2011 ; Vol. 22, No. 3. pp. 146-150.
@article{55e29c7eacf848d98de30106dd467650,
title = "Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection",
abstract = "The rapid evolution of HIV-1 is a major obstacle to viral eradication. Early antiretroviral therapy (ART) during primary HIV-1 infection could limit viral diversity. Eighteen patients recently infected with HIV-1 were selected. Nine initiated ART soon after enrolment and nine remained untreated. Replication-competent (RC) viruses were quanstified at baseline and after one year of follow-up. Viral diversity in the C2V5 envelope region was evaluated from plasma, peripheral blood mononuclear cells (PBMCs), and cell culture at both time points. The amount of RC virus in the treated group declined (median -5.42 infectious units per million [IUPM]) while it remained stable or increased in the untreated group (median +0.87 IUPM). At one year post infection, we observed a significant increase in diversity for the C2V5 (+0.150{\%}) region, specifically in the hypervariable loops V4 (+0.73{\%}) and V5 (+0.77{\%}), in the untreated group. More importantly, viral diversity did not significantly increase in treated individuals during the first year post infection. Genetic diversity during primary infection remains low through the first year of infection. Early treatment could contribute to a decrease in RC viruses from PBMCs and to limitation of viral diversification in the viral reservoir. These findings may have relevance for the rational design of specific immunotherapeutic strategies.",
keywords = "Acute infection, Primary HIV-1, Sequence diversity, Treatment",
author = "A. Chamberland and M. Sylla and Boulassel, {M. R.} and Baril, {J. G.} and P. C{\^o}t{\'e} and R. Thomas and B. Trottier and D. Rouleau and Routy, {J. P.} and C. Tremblay",
year = "2011",
month = "3",
doi = "10.1258/ijsa.2010.010292",
language = "English",
volume = "22",
pages = "146--150",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection

AU - Chamberland, A.

AU - Sylla, M.

AU - Boulassel, M. R.

AU - Baril, J. G.

AU - Côté, P.

AU - Thomas, R.

AU - Trottier, B.

AU - Rouleau, D.

AU - Routy, J. P.

AU - Tremblay, C.

PY - 2011/3

Y1 - 2011/3

N2 - The rapid evolution of HIV-1 is a major obstacle to viral eradication. Early antiretroviral therapy (ART) during primary HIV-1 infection could limit viral diversity. Eighteen patients recently infected with HIV-1 were selected. Nine initiated ART soon after enrolment and nine remained untreated. Replication-competent (RC) viruses were quanstified at baseline and after one year of follow-up. Viral diversity in the C2V5 envelope region was evaluated from plasma, peripheral blood mononuclear cells (PBMCs), and cell culture at both time points. The amount of RC virus in the treated group declined (median -5.42 infectious units per million [IUPM]) while it remained stable or increased in the untreated group (median +0.87 IUPM). At one year post infection, we observed a significant increase in diversity for the C2V5 (+0.150%) region, specifically in the hypervariable loops V4 (+0.73%) and V5 (+0.77%), in the untreated group. More importantly, viral diversity did not significantly increase in treated individuals during the first year post infection. Genetic diversity during primary infection remains low through the first year of infection. Early treatment could contribute to a decrease in RC viruses from PBMCs and to limitation of viral diversification in the viral reservoir. These findings may have relevance for the rational design of specific immunotherapeutic strategies.

AB - The rapid evolution of HIV-1 is a major obstacle to viral eradication. Early antiretroviral therapy (ART) during primary HIV-1 infection could limit viral diversity. Eighteen patients recently infected with HIV-1 were selected. Nine initiated ART soon after enrolment and nine remained untreated. Replication-competent (RC) viruses were quanstified at baseline and after one year of follow-up. Viral diversity in the C2V5 envelope region was evaluated from plasma, peripheral blood mononuclear cells (PBMCs), and cell culture at both time points. The amount of RC virus in the treated group declined (median -5.42 infectious units per million [IUPM]) while it remained stable or increased in the untreated group (median +0.87 IUPM). At one year post infection, we observed a significant increase in diversity for the C2V5 (+0.150%) region, specifically in the hypervariable loops V4 (+0.73%) and V5 (+0.77%), in the untreated group. More importantly, viral diversity did not significantly increase in treated individuals during the first year post infection. Genetic diversity during primary infection remains low through the first year of infection. Early treatment could contribute to a decrease in RC viruses from PBMCs and to limitation of viral diversification in the viral reservoir. These findings may have relevance for the rational design of specific immunotherapeutic strategies.

KW - Acute infection

KW - Primary HIV-1

KW - Sequence diversity

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=79955382045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955382045&partnerID=8YFLogxK

U2 - 10.1258/ijsa.2010.010292

DO - 10.1258/ijsa.2010.010292

M3 - Article

C2 - 21464451

AN - SCOPUS:79955382045

VL - 22

SP - 146

EP - 150

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 3

ER -